vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and PJT Partners Inc. (PJT). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $531.4M, roughly 1.8× PJT Partners Inc.). PJT Partners Inc. runs the higher net margin — 10.0% vs 0.7%, a 9.4% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 12.9%). PJT Partners Inc. produced more free cash flow last quarter ($138.6M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 27.5%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
ASTH vs PJT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $950.5M | $531.4M |
| Net Profit | $6.6M | $53.4M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 23.1% |
| Net Margin | 0.7% | 10.0% |
| Revenue YoY | 42.9% | 12.9% |
| Net Profit YoY | 184.4% | 4.0% |
| EPS (diluted) | $0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $531.4M | ||
| Q3 25 | $956.0M | $442.3M | ||
| Q2 25 | $654.8M | $401.1M | ||
| Q1 25 | $620.4M | $321.9M | ||
| Q4 24 | $665.2M | $470.5M | ||
| Q3 24 | $478.7M | $320.3M | ||
| Q2 24 | $486.3M | $358.1M | ||
| Q1 24 | $404.4M | $327.1M |
| Q4 25 | $6.6M | $53.4M | ||
| Q3 25 | $373.0K | $39.8M | ||
| Q2 25 | $9.4M | $32.9M | ||
| Q1 25 | $6.7M | $54.0M | ||
| Q4 24 | $-7.8M | $51.3M | ||
| Q3 24 | $16.1M | $22.1M | ||
| Q2 24 | $19.2M | $28.3M | ||
| Q1 24 | $14.8M | $32.6M |
| Q4 25 | 1.9% | 23.1% | ||
| Q3 25 | 2.0% | 20.6% | ||
| Q2 25 | 3.1% | 19.1% | ||
| Q1 25 | 3.3% | 16.3% | ||
| Q4 24 | 0.1% | 21.9% | ||
| Q3 24 | 5.9% | 15.4% | ||
| Q2 24 | 6.2% | 18.0% | ||
| Q1 24 | 7.5% | 16.5% |
| Q4 25 | 0.7% | 10.0% | ||
| Q3 25 | 0.0% | 9.0% | ||
| Q2 25 | 1.4% | 8.2% | ||
| Q1 25 | 1.1% | 16.8% | ||
| Q4 24 | -1.2% | 10.9% | ||
| Q3 24 | 3.4% | 6.9% | ||
| Q2 24 | 3.9% | 7.9% | ||
| Q1 24 | 3.7% | 10.0% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $538.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $308.2M |
| Total Assets | $2.2B | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $538.9M | ||
| Q3 25 | $463.4M | $400.5M | ||
| Q2 25 | $342.1M | $214.6M | ||
| Q1 25 | $260.9M | $194.3M | ||
| Q4 24 | $290.8M | $483.9M | ||
| Q3 24 | $350.3M | $148.8M | ||
| Q2 24 | $327.7M | $164.2M | ||
| Q1 24 | $337.3M | $215.5M |
| Q4 25 | $779.3M | $308.2M | ||
| Q3 25 | $775.5M | $228.6M | ||
| Q2 25 | $765.5M | $167.4M | ||
| Q1 25 | $745.4M | $148.8M | ||
| Q4 24 | $712.7M | $187.0M | ||
| Q3 24 | $704.6M | $159.1M | ||
| Q2 24 | $678.9M | $133.8M | ||
| Q1 24 | $653.5M | $174.6M |
| Q4 25 | $2.2B | $1.8B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.4B | $1.6B | ||
| Q3 24 | $1.3B | $1.6B | ||
| Q2 24 | $1.3B | $1.4B | ||
| Q1 24 | $1.2B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $155.7M |
| Free Cash FlowOCF − Capex | $-6.0M | $138.6M |
| FCF MarginFCF / Revenue | -0.6% | 26.1% |
| Capex IntensityCapex / Revenue | 0.3% | 3.2% |
| Cash ConversionOCF / Net Profit | -0.44× | 2.92× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $480.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $155.7M | ||
| Q3 25 | $10.0M | $256.1M | ||
| Q2 25 | $90.9M | $190.4M | ||
| Q1 25 | $16.6M | $-75.9M | ||
| Q4 24 | $-10.9M | $195.7M | ||
| Q3 24 | $34.0M | $180.5M | ||
| Q2 24 | $23.2M | $193.6M | ||
| Q1 24 | $6.0M | $-38.8M |
| Q4 25 | $-6.0M | $138.6M | ||
| Q3 25 | $7.4M | $240.9M | ||
| Q2 25 | $89.5M | $178.9M | ||
| Q1 25 | $13.6M | $-77.9M | ||
| Q4 24 | $-13.5M | $195.3M | ||
| Q3 24 | $31.7M | $178.5M | ||
| Q2 24 | $20.4M | $193.0M | ||
| Q1 24 | $5.6M | $-39.2M |
| Q4 25 | -0.6% | 26.1% | ||
| Q3 25 | 0.8% | 54.5% | ||
| Q2 25 | 13.7% | 44.6% | ||
| Q1 25 | 2.2% | -24.2% | ||
| Q4 24 | -2.0% | 41.5% | ||
| Q3 24 | 6.6% | 55.7% | ||
| Q2 24 | 4.2% | 53.9% | ||
| Q1 24 | 1.4% | -12.0% |
| Q4 25 | 0.3% | 3.2% | ||
| Q3 25 | 0.3% | 3.4% | ||
| Q2 25 | 0.2% | 2.9% | ||
| Q1 25 | 0.5% | 0.6% | ||
| Q4 24 | 0.4% | 0.1% | ||
| Q3 24 | 0.5% | 0.6% | ||
| Q2 24 | 0.6% | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
| Q4 25 | -0.44× | 2.92× | ||
| Q3 25 | 26.69× | 6.43× | ||
| Q2 25 | 9.65× | 5.79× | ||
| Q1 25 | 2.48× | -1.41× | ||
| Q4 24 | — | 3.81× | ||
| Q3 24 | 2.11× | 8.15× | ||
| Q2 24 | 1.21× | 6.84× | ||
| Q1 24 | 0.40× | -1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
PJT
Segment breakdown not available.